Treatment type: Cell therapies

A cell therapy could reduce inflammatory response in liver disease, offering hope to thousands of Australians suffering from the disease.…  Read more

A researcher developing 3D bioprinted mesh for use in treating pelvic organ prolapse (POP) has received a Victoria Fellowship, allowing him to travel overseas to further his research into bioinks.…  Read more

Neural Stem Cells have strong potential to be effective in reducing brain injury in newborn babies, in the most extensive review of research on the topic.…  Read more

A promising early intervention treatment for cerebral palsy in newborn babies has proven effective in both boys and girls – even though it works differently depending on the sex of the offspring.…  Read more

A new discovery about a major cause of male infertility could have significant impacts for millions of men worldwide.…  Read more

RNA therapeutics comprise a rapidly expanding category of drugs that have the potential to revolutionise treatments for many diseases, including those currently deemed undruggable.…  Read more

condition that affects about one in 10 women of reproductive age and more than 730,000 in Australia, after making a world-first discovery of the role endometrial stem/progenitor cells in the disease.…  Read more

Hudson Institute researchers have developed a new gene therapy strategy to treat beta thalassaemia, an inherited disorder where the body doesn’t make enough haemoglobin in red blood cells. These disorders lead to altered production of both haemoglobin and red blood cells, causing serious life-threatening complications soon after birth. …  Read more

It took 20 years for Nicole Fernley to be diagnosed with endometriosis, a condition which affects one in nine women. This is her story, in her words.…  Read more

Research into a chronic lung disease in premature babies is leading Hudson Institute researchers to develop new protocols on how to treat infants with cell-based therapies. …  Read more